刊名:Indian Journal of Hematology and Blood Transfusion
出版年:2012
出版时间:September 2012
年:2012
卷:28
期:3
页码:189-190
全文大小:130KB
参考文献:1. Roy L, Guilhot J, Martineau G, Larch茅e R, Guilhot F (2005) Unexpected occurrence of second malignancies in patients treated with interferon followed by imatinib mesylate for chronic myelogenous leukemia. Leukemia 19(9):1689鈥?692 CrossRef 2. Verma D, Kantarjian H, Strom SS, Cortes M, Jabbour E, Quintas-Cardama A et al (2011) Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies. Blood 16 Aug. doi:10.1182/blood-2011-06-362889 3. Aichberger KJ, Herndlhofer S, Schernthaner GH, Schillinger M, Mitterbauer-Hohendanner G, Sillaber C et al (2011) Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML. Am J Hematol 86(7):533鈥?39 CrossRef 4. Le Coutre P, Rea D, Abruzzese E, Dombret H, Trawinska MM, Herndlhofer S et al (2011) Severe peripheral arterial disease during nilotinib therapy. J Natl Cancer Inst 103(17):1347鈥?348 CrossRef 5. Jabbour EJ (2010) Tyrosine kinase inhibitors in CML: applying new data to practice 鈥?an expert interview with Dr. Elias J. Jabbour from ASH 2009 held in New Orleans, Louisiana, CME Released Medscape Education Oncology
1. Department of Pathology & Hematology, Calcutta School of Tropical Medicine, C.R. Avenue, Kolkata, 73, WB, India 2. Calcutta School of Tropical Medicine, 108 CR Avenue, Kolkata, 73, India 3. 7/51 Purbapalli, Sodepur, 24 Parganas (North), Kolkata, 110, WB, India 4. Swamijinagar, South Habra 24 Parganas (North), Kolkata, WB, India 5. Department of Pathology, IPGME&R, Kolkata, 20, WB, India